Kellanova (K) has been consistently dominating news with notable follow-ups on its performance, split-up from Kellogg, earnings and dividends along with major institutional buy and sell orders. The biotech company intends to
issue a quarterly dividend of $0.57 on September 13. However, various institutions like American International Group, US Bancorp DE, and Kingsview Wealth Management have
sold considerable shares of the company, whereas, CANADA LIFE ASSURANCE Co and Norden Group LLC
increased their stake. The company’s stock price target has been
reduced to $60.00. Nevertheless, there's a considerable undervaluation of the company's shares with a
44% undervaluation highlighted. Moreover, Kellanova witnessed a major shareholder selling a substantial portion of their shares, possibly indicating potential challenges. However, the firm received a score as a
top-rank value stock and demonstrated an optimistic
earnings beat in Q4. Furthermore, the company, despite having split up from Kellogg, faced a dip in stocks on the first trading day. Kellanova’s reliance on
international revenue and future separation plans continue to play a key role in the company's fluctuations.
Kellanova Stocks K News Analytics from Wed, 15 Mar 2023 07:00:00 GMT to Sun, 28 Jul 2024 11:32:49 GMT -
Rating -2
- Innovation 6
- Information 8
- Rumor -4
